SUTRO BIOPHARMA, INC. — Director's Dealing 2018

Sep 27, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SUTRO BIOPHARMA INC (STRO)
CIK: 0001382101
Period of Report: 2018-09-26

Reporting Person: MOLINA ARTURO MD (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities beneficially held	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy Common Stock)	$14.16	2026-02-23	Common Stock (98070)		Direct

Footnotes

F1: The option vested as to 25% of the total shares on February 22, 2017 and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on February 22, 2020, subject to the reporting person's provision of service to the issuer on each vesting date.